Olten, Switzerland

Lorenzo Codan

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 3 CIPO patents. Top assignee: Intervet Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorenzo Codan: Innovator in Pharmaceutical Chemistry

Introduction

Lorenzo Codan is a notable inventor based in Olten, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific medical conditions. His work is characterized by a focus on innovative solutions for treating diseases.

Latest Patents

Lorenzo Codan holds a patent for a compound titled "Crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide." This patent relates to the crystalline forms of the compound and the processes for its preparation. The compound is particularly useful for the treatment of JAK-mediated diseases or conditions, such as atopic dermatitis. He has 1 patent to his name.

Career Highlights

Lorenzo Codan is associated with Intervet Inc., where he applies his expertise in pharmaceutical development. His work has contributed to advancements in the treatment of various medical conditions, showcasing his commitment to innovation in the healthcare sector.

Collaborations

Lorenzo has collaborated with several professionals in his field, including Christophe Pierre Alain Chassaing and Xiaoling Jin. These collaborations have further enhanced the impact of his research and development efforts.

Conclusion

Lorenzo Codan is a distinguished inventor whose work in pharmaceutical chemistry has the potential to improve treatment options for patients with JAK-mediated diseases. His innovative approach and dedication to research continue to make a significant impact in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…